User: Guest  Login
Title:

[PSMA-targeted radioligand therapy in prostate cancer].

Document type:
journal article
Author(s):
Heck, M M; Retz, M; Tauber, R; Knorr, K; Kratochwil, C; Eiber, M
Abstract:
Radioligand therapy (RLT) directed against prostate-specific membrane antigen (PSMA) enables tumor-specific treatment directed against PSMA-overexpressing prostate cancer cells. Several PSMA ligands such as PSMA-617 or PSMA-I&T; have been developed that can be labeled with ?-radiating lutetium-177. These are currently applied in compassionate use programs to treat metastatic castration-resistant prostate cancer (mCRPC). PSMA-directed RLT is currently being offered in several nuclear medicine depar...     »
Journal title abbreviation:
Urologe A
Year:
2017
Journal volume:
56
Journal issue:
1
Pages contribution:
32-39
Language:
de
Fulltext / DOI:
doi:10.1007/s00120-016-0274-3
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/27885457
Print-ISSN:
0340-2592
TUM Institution:
Klinik und Poliklinik für Nuklearmedizin
 BibTeX